Delivery of high dose VEGF plasmid using fibrin carrier does not influence its angiogenic potency

International Journal of Artificial Organs

Volumn 26, Issue 2, 2003, Pages 161-169

  Jozkowicz, Alicja ^a,b   Fugl A ^a,c   Nanobashvili, J ^a,c   Neumayer, C ^a   Dulak, J ^b   Valentini, D ^c   Funovics, P ^a   Polterauer, P ^c   Redl, H ^c   Huk, I ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Angiogenesis; Fibrin sealant; Gene therapy; Hind limb ischemia; Vascular endothelial growth factor

Indexed keywords

ANIMALS; ENDOTHELIAL CELLS; GENE THERAPY; MUSCLE; SEALANTS;

ANGIOGENESIS; FIBRIN SEALANTS; HIGH DOSE; HIND LIMBS; HIND-LIMB ISCHEMIA; ISCHAEMIA; ISCHEMIA MODEL; MATRIX; TRANSGENE EXPRESSION; VASCULAR ENDOTHELIAL GROWTH FACTOR;

DNA;

DRUG CARRIER; FIBRIN GLUE; GENE PRODUCT; MESSENGER RNA; PLASMID VECTOR; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN 5 VASCULOTROPIN 165; PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ANALYSIS OF VARIANCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENCY; FEMALE; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENETIC CODE; INJECTION; LIMB ISCHEMIA; MALE; MUSCLE; NONHUMAN; PROTEIN SYNTHESIS; RABBIT; TRANSGENE; ANIMAL; DRUG EFFECT; EVALUATION; GENETICS; HINDLIMB; IMMUNITY; IMMUNOLOGY; ISCHEMIA; PHYSIOLOGY; PLASMID; SKELETAL MUSCLE; VASCULARIZATION;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBRIN TISSUE ADHESIVE; GENE EXPRESSION; GENE THERAPY; HINDLIMB; IMMUNITY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIA; LYMPHOKINES; MALE; MODELS, ANIMAL; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038605960     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600211     Document Type: Article

References (44)

1. Schaper W, Buschmann I. VEGF and therapeutic opportunities in cardiovascular diseases. Curr Opin Biotechnol 1999; 10: 541-3.
2. Takeshita S, Isshiki T, Ochiai M, et al. Endothelium-dependent relaxation of collateral microvessels after intramuscullar gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98: 2161-3.
3. Takeshita S, Tsurumi Y, Couffinahl T, et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1996; 75: 487-501.
4. Tsurumi Y, Kearney M, Chen D, et al. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997; 96 (suppl 9): S382-8.
5. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94: 3281-90.
6. Dulak J, Partyka L, Jozkowicz A, et al. Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischemic limb muscles. Eur Surg 2002; 34: 105-10.
7. Takeshita S, Isshiki T, Mon H, et al. Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats. Cardiovasc Res 1997; 35: 547-52.
8. Gowdak LH, Poliakowa L, Grove R, Lakaffa EG, Talan M. Induction of angiogenesis by cationic lipid-mediated VEGF-165 gene transfer in the rabbit ischemic hindlimb. J Vasc Surg 2000; 32: 343-52.
9. Neumeister MW, Song YH, Mowlavi A, Suchy H, Mathur A. Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracilis muscle. Microsurgery 2001; 21: 58-62.
10. Weisz A, Koren B, Fischer L, Lewis BS, Flugelman MY. Therapeutic angiogenesis for ischemic syndromes. Isr Med Assoc 2000; 2; 52-7.
11. Rivard A, Silver M, Chen D, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154: 355-63.
12. Shimpo M, Ikeda U, Maeda Y, et al. Cardiovasc Res 2002; 53: 993-1001.
13. Masaki I, Yonemitsu Y, Yamashita A, et al. Circ Res 2002; 90: 966-73.
14. Bonadio J, Goldstein SA, Levy RJ. Gene therapy for tissue repair and regeneration. Adv Drug Deliv Rev 1998; 33: 53-69.
15. Ochiya T, Takahama Y, Nagahara S, et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: The minipellet. Nat Med 1999; 5: 707-9.
16. Bonadio J, Smiley E, Patil P, Goldstein S. Localizes, direct plasmid-gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 1999; 5: 753-9.
17. Bonadio J. Tissue engineering via local gene delivery: Update and future prospects for enhancing the technology. Adv Drug Deliv Rev 2000; 44: 185-94.
18. Han S, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Mol Ther 2000; 2: 302-17.
19. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteoinductive plasmid genes. Proc Natl Acad Sci 1996; 93: 5753-8.
20. Klughertz BD, Jones PL, Cui X, Chen W, Meneveau NF, De Felice S, et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 2000; 18: 1181-4.
21. Koh JJ, Ko KS, Lee M, Han S, Park JS, Kim SW. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther 2000; 7: 2099-104.
22. Maheshwari A, Mahato RI, McGregor J, et al. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol Ther 2000; 2: 121-30.
23. Redl H, Schlag G, Stanek G, Hirschl A, Seelich T. In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials 1983; 4: 29-32.
24. Zisch AH, Schenk U, Schense JC, Sakiyama-Elberg SE, Hubbell JA. Covalently conjugates VEGF-fibrin matrices for endothelialization. J Control Rel 2001; 72: 101-13.
25. Kipshidze N, Chekanov V, Chawla P, Shankar LR, Gosset JB, Kumar K, et al. Angiogenesis in patient with ischemic limb. Induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. Tex Heart Inst J 2000; 27: 196-200.
26. Clark RAF, Lanigan JM, DellaPelle P, Mansequ E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79: 264-9.
27. Chekanov V, Nikolaychik V, Tchekanov G. The use of biologic glue for beffer adhesion between the skeletal muscle flap and the myocardium and for increasing capillary ingrowth. J Thorac Cardiovasc Surg 1996; 111: 678-80.
28. Chekanov VS, Tchekanov GV, Rieder MA, et al. Biologic glue increases capillary growth after cardiomyoplasty in an ischemic cardiomyopathy model. ASAIO J 1996; 42: M630-6.
29. Dulak J, Józkowicz A, Guevara I, Dembińska-Kieć. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase - Implications for gene therapy in cardiovascular disease. Pol J Pharmacol 1999; 51: 233-41.
30. Dulak J, Józkowicz A, Ratajska A, Szuba A, Cooke JP, Dembińska-Kiec A. Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSGSVEGF plasmids in vascular smooth muscle cells. Vasc Med 2000; 5: 33-40.
31. Maniatis T, Fritsch EF, Sambrook J. 1982. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratories.
32. Takeshita S, Weir L, Chen D, et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in rabbit model of hindlimb ischemia. Biochem Biophys Res Commun 1996; 227: 628-35.
33. Watkins R, D'Angio CT, Ryan RM, Patel A, Maniscalco WM. Differential expression of VEGF mRNA splice variants in newborn and adult hypoxic lung injury. Am J Physiol 1999; 276: L858-67.
34. Ziada AM, Hudlicka G, Tyler KR, Wright AJ. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 1984; 18: 724-32.
35. Majesky M. A little VEGF goes a long way. Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation 1996; 94: 3062-4.
36. Cherng JM, Lin CM, Lin CL, Huang SM, Chang HL, Lee CC, et al. Effects of VEGFI21 and/or VEGF 165 gene transfection on collateral circulation developments. J Formos Med Assoc 2000; 99: 603-11.
37. Ismail FA, Napaporn J, Hughes JA, Brazeau GA. In situ gel formulation for gene delivery: Release and myotoxicity studies. Pharm Dev Technol 2000; 5: 391-7.
38. Bonadio J. Tissue engineering via local gene delivery. J Mol Med 2000; 78: 303-11.
39. Berry M, Gonzalez AM, Clarke W, et al. Sustained effects of gene activated matrices after CNS injury. Mol Cell Neurosci 2001; 17: 706-16.
40. Labhasetwar V, Bonadio J, Goldstein S, Chen W, Levy RI. A DNA controlled-release coating for gene transfer: Transfection in skeletal muscle and cardiac muscle. J Pharm Sci 1998; 87: 1347-50.
41. Shea LD, Smilney E, Bonadio J, Mooney DJ. Controllable DNA delivery from three-dimensional polymer matrices. Nat Biotechnol 1999; 17: 551-4.
42. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh A, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987; 57: 673-86.
43. Ghulam MAK, Yoshimine T, Maruno M, Takemoto O, Hayakawa T. Topical application of fibrin adhesive in the rat brain: Effects on different cellular elements of the wound. Neurol Res 1997; 19: 84-8.
44. Fasol R, Schumacher B, Schlaudraff K, Hausenstein KH, Seitelberger R. Experimental use of the modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg 1994; 107: 1432-9.